Subsidiary14 Aug 2026, 08:10 pm
Gufic Biosciences to Incorporate Subsidiary in Philippines
AI Summary
Gufic Biosciences Ltd announced its Board of Directors has approved the incorporation of a subsidiary in the Philippines. The company will invest up to USD 250,000 to subscribe to the equity share capital, aiming to hold approximately 99.99% of the subsidiary. The new entity, tentatively named Gufic Philippines Inc., will focus on marketing, sales, and distribution of Gufic's pharmaceutical products in the Philippines, facilitating business expansion and IP management in the region. The incorporation is subject to statutory and regulatory approvals.
Key Highlights
- Board approves incorporation of a new subsidiary in the Philippines.
- Investment of up to USD 250,000 for equity subscription.
- Subsidiary to handle marketing, sales, and distribution of pharma products.
- Aims to expand Gufic's presence and manage IP in the Philippines.
- Gufic Biosciences will hold ~99.99% stake in the new entity.
Price Impact
More from GUFICBIO